Recombinant Human INSM2 Protein，His & GST

INSM2 (Insulinoma-Associated Protein 2) is a transcription factor that plays a pivotal role in neuroendocrine differentiation and development, particularly in the context of neuroendocrine tumors. It is primarily expressed during embryogenesis and is associated with the regulation of insulin secretion and neuronal differentiation. Recent studies have highlighted the significance of INSM2 in the pathogenesis of various cancers, such as neuroblastoma and small cell lung cancer, where it serves as a potential biomarker for diagnosis and prognosis. The recombinant protein of INSM2 has gained attention in the research community for its potential applications in cancer therapy and diagnostics. By utilizing recombinant DNA technology, researchers can produce INSM2 protein in vitro, allowing for detailed analysis of its structural and functional properties. This research not only helps elucidate the molecular mechanisms by which INSM2 contributes to tumorigenesis but also paves the way for developing novel immunotherapeutic approaches targeting INSM2. Moreover, understanding the interactions of INSM2 with other signaling pathways can provide insights into its role in cellular processes such as proliferation, survival, and differentiation. As such, the characterization of recombinant INSM2 protein is fundamental to advancing our knowledge of neuroendocrine biology and improving therapeutic strategies for related malignancies.